nach oben

Journal of Thrombosis and Thrombolysis

Erschienen in:

01.04.2012

Retrievable vena cava filters: a clinical review

verfasst von: Davide Imberti, Walter Ageno, Francesco Dentali, Marco Donadini, Roberto Manfredini, Massimo Gallerani

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism (PE), is a major cause of morbidity and mortality. Parenteral anticoagulant treatment with full-dose unfractioned heparin, low-molecular-weight-heparin, or fondaparinux, followed by oral treatment with the vitamin K antagonists, is recommended for the majority of patients. However, in the presence of contraindications to anticoagulant treatment, bleeding complications during antithrombotic treatment, or VTE recurrences despite optimal anticoagulation, interruption of the inferior vena cava with a filter is a potential option aimed to prevent life-threatening PE. Currently, the vast majority of filters implanted worldwide are of the permanent type, but their use is associated with a number of long term complications. Non-permanent filters represent an important alternative, and in particular retrievable filters are an attractive option because they may be either left in place permanently or safely retrieved after a quite long period when they become unnecessary. In this review, we summarize the currently available literature regarding retrievable vena cava filters and we discuss current evidences on their efficacy and safety. Moreover, the appropriate indications for their use in daily clinical practice are reviewed.

White RH (2003) The epidemiology of venous thromboembolism. Circulation 107:I-4–I-8CrossRef

Dentali F, Ageno W, Imberti D (2006) Retrievable vena cava filters: clinical experience. Curr Opin Pulm Med 12:304–309PubMed

Kearon C, Kahn SR, Agnelli G et al (2008) American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133(6 Suppl):454S–545SPubMedCrossRef

Imberti D, Prisco D (2008) Retrievable vena cava filters: key considerations. Thromb Res 122:442–449PubMedCrossRef

Young T, Tang H, Hughes R (2010) Vena caval filters for the prevention of pulmonary embolism. Cochrane Database Syst Rev 2(2):CD006212PubMed

Athanasoulis C (2000) Inferior vena cava filters: review of a 26-year single center clinical experience. Radiology 216:54–66PubMed

Stein PD, Kayali F, Olson RE (2004) Twenty-one year trends in the use of inferior vena cava filters. Arch Intern Med 164:1541–1545PubMedCrossRef

Spencer FA, Bates SM, Goldberg RJ et al (2010) A population-based study of inferior vena cava filters in patients with acute venous thromboembolism. Arch Intern Med 170:1456–1462PubMedCrossRef

Decousus H, Leizorovicz A, Parent F et al (1998) A clinical trial of vena cava filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 338:409–415PubMedCrossRef

10.

Duszak R, Parker L, Levin D et al (2011) Placement and removal of inferior vena cava filters: national trends in the medicare population. J Am Coll Radiol 89:483–489CrossRef

11.

U.S. Food and Drug Administration (2010) Removing retrievable inferior vena cava filters: initial communication. Available at http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm221676.htm. Accessed 1 Nov 2010

12.

Millward SF, Oliva VL, Bell SD et al (2001) Gunther Tulip retrievable vena cava filter: results from the registry of the Canadian Interventional Radiology Association. J Vasc Interv Radiol 12:1053–1058PubMedCrossRef

13.

Ponchon M (1999) Temporary vena cava filtration. Preliminary experience with removable vena cava filters. Acta Clin Belg 54:223–228PubMed

14.

Offner PJ, Hawkes A, Madayag R et al (2003) The role of temporary inferior vena cava filters in critically ill surgical patients. Arch Surg 138:591–595PubMedCrossRef

15.

Morris CS, Rogers FB, Najarian KE et al (2004) Current trends in vena cava filtration with the introduction of a retrievable filter at a level I trauma center. J Trauma 57:32–36PubMedCrossRef

16.

Neuerburg GM, Gunther RW, Vorwerk D et al (1997) Results of a multicenter study of the retrievable Tulip vena cava filters: preliminary early clinical experience. Cardiovasc Intervent Radiol 20:10–16PubMedCrossRef

17.

Ray CE, Mitchell E, Zipser S et al (2006) Outcomes with retrievable inferior vena cava filters: a multicenter study. J Vasc Interv Radiol 17:1595–1604PubMedCrossRef

18.

Pieri S, Agresti M, Morucci M et al (2003) Optional vena cava filters: preliminary experience with a new vena cava filter. Radiol Med 105:56–62PubMed

19.

Barral F, Tardy B, Guillot K et al (2003) Clinical experience with optional cava filters. J Thromb Haemost 1(Suppl 1):OC441

20.

Pancione L, Mecozzi B (2004) Permanent/removable vena cava filter ALN (France): our experience with 96 patients. Abstract SSJ03, Proceedings of 90th Annual Meeting of the Radiological Society of North America, Chicago, 28 Nov–3 Dec 2004

21.

Imberti D, Bianchi M, Farina A et al (2005) Clinical experience with retrievable vena cava filters: results of a prospective observational study. J Thromb Haemost 3:1370–1375PubMedCrossRef

22.

Mismetti P, Rivron-Guillot K, Quenet S et al (2007) A prospective long-term study of 220 patients with a retrievable vena cava filter for secondary prevention of venous thromboembolism. Chest 131:223–229PubMedCrossRef

23.

Pancione L, Pieri S, Agresti P et al (2006) Use of the ALN permanent/removable vena cava filter. A multi-centre experience. Minerva Chir 61:501–507PubMed

24.

Pellerin O, Barral FG, Lions C et al (2008) Early and late retrieval of the ALN removable vena cava filter: results from a multicenter study. Cardiovasc Intervent Radiol 31:889–896PubMedCrossRef

25.

Rosenthal D, Wellons ED, Lai KM, Bikk A, Henderson VJ (2006) Retrievable inferior vena cava filters: initial clinical results. Ann Vasc Surg 20:157–165PubMedCrossRef

26.

Asch MR (2002) Initial experience in humans with a new retrievable inferior vena cava filter. Radiology 225:835–844PubMedCrossRef

27.

Grande WJ, Trerotola SO, Reilly PM et al (2005) Experience with the Recovery filter as a retrievable inferior vena cava filter. J Vasc Interv Radiol 16:1189–1193PubMedCrossRef

28.

Stefanidis D, Paton BL, Jacobs DG et al (2006) Extended interval for retrieval of vena cava filters is safe and may maximize protection against pulmonary embolism. Am J Surg 192:789–794PubMedCrossRef

29.

de Villiers L, Mackenzie S, Gibbs H et al (2008) Initial Australian experience with the recovery inferior vena cava filter in patients with increased risk of thromboembolic disease. J Med Imaging Radiat Oncol 52:124–129PubMedCrossRef

30.

Oliva VL, Perreault P, Giroux MF et al (2008) Recovery G2 inferior vena cava filter: technical success and safety of retrieval. J Vasc Interv Radiol 19:884–889PubMedCrossRef

31.

Cantwell CP, Pennypacker J, Singh H et al (2009) Comparison of the recovery and G2 filter as retrievable inferior vena cava filters. J Vasc Interv Radiol 20:1193–1199PubMedCrossRef

32.

Binkert CA, Drooz AT, Caridi JG et al (2009) Technical success and safety of retrieval of the G2 filter in a prospective, multicenter study. J Vasc Interv Radiol 20:1449–1453PubMedCrossRef

33.

Oliva VL, Szatmari F, Giroux MF et al (2005) The Jonas study: evaluation of the retrievability of the Cordis OptEase inferior vena cava filter. J Vasc Interv Radiol 16:1439–1445PubMedCrossRef

34.

Rosenthal D, Swischuk JL, Cohen SA, Wellons ED (2005) OptEase retrievable inferior vena cava filter: initial multicenter experience. Vascular 13:286–289PubMed

35.

Ziegler JW, Dietrich GJ, Cohen SA et al (2008) PROOF trial: protection from pulmonary embolism with the OptEase filter. J Vasc Interv Radiol 19:1165–1170PubMedCrossRef

36.

Onat L, Ganiyusufoglu AK, Mutlu A et al (2009) OptEase and TrapEase vena cava filters: a single-center experience in 258 patients. Cardiovasc Intervent Radiol 32:992–997PubMedCrossRef

37.

Kalva SP, Marentis TC, Yeddula K et al (2011) Long-term safety and effectiveness of the “OptEase” vena cava filter. Cardiovasc Intervent Radiol 34:331–337PubMedCrossRef

38.

Geerts WH, Bergqvist D, Pineo GF et al (2008) Prevention of venous thromboembolism. American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl):381S–453SPubMedCrossRef

39.

Imberti D, Ageno W, Carpenedo M (2006) Retrievable vena cava filters: a review. Curr Opin Hematol 13:351–356PubMedCrossRef

40.

Geerts WH, Code JI, Jay RM et al (1994) A prospective study of venous thromboembolism after major trauma. N Engl J Med 331:1601–1606PubMedCrossRef

41.

Sevitt S (1968) Fatal road accidents: injuries, complications, and causes of death in 250 subjects. Br J Surg 55:481–505PubMedCrossRef

42.

Rutherford RB (2005) Prophylactic indications for vena cava filters: critical appraisal. Semin Vasc Surg 18:158–165PubMedCrossRef

43.

Imberti D, Squizzato A, Ageno W (2005) A survey of thromboprophylaxis management in patients with major trauma. J Pathophysiol Haemost Thromb 34:249–254CrossRef

44.

Rectenwald JE (2005) Vena cava filters: uses and abuses. Semin Vasc Surg 18:166–175PubMedCrossRef

45.

Gosin IS, Graham AM, Ciocca RG et al (1997) Efficacy of prophylactic vena cava filters in high risk trauma patients. Ann Vasc Surg 11:100–105PubMedCrossRef

46.

Rogers FB, Shackford SR, Ricci MA et al (1995) Routine prophylactic vena cava filter insertion in severely injured patients decreases the incidence of pulmonary embolism. J Am Coll Surg 180:641–647PubMed

47.

Spain DA, Richardson JD, Polk HC et al (1997) Venous thromboembolism in the high-risk trauma patient: do risks justify aggressive screening and prophylaxis? J Trauma 42:463–467PubMedCrossRef

48.

Karmy-Jones R, Jurkovich G, Velmahos G et al (2007) Practice patterns and outcomes of retrievable vena cava filters in trauma patients: an AAST multicenter study. J Trauma 62:17–25PubMedCrossRef

49.

Lorch H, Welger D, Wagner V et al (2000) Current practice of temporary vena cava filter insertion: a multicenter registry. J Vasc Intervent Radiol 11:83–88CrossRef

50.

Bates SM, Greer IA, Pabinger I et al (2008) Venous thromboembolism, thrombophilia, antithrombotic therapy and pregnancy. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133(6 Suppl):844S–886SPubMedCrossRef

51.

Neil AM, Appleton DS, Richards P (1997) Retrievable inferior vena cava filters for thromboembolic disease in pregnancy. Br J Obstet Gynaecol 104:1416–1417CrossRef

52.

Neri E, Civeli L, Benvenuti A et al (2002) Protected ileofemoral venous thrombectomy in a pregnant woman with pulmonary embolism and ischemic vein thrombosis. Tex Heart Inst J 29:130–132PubMed

53.

Ishikawa T, Okabe T, Ogawa K et al (2003) Usefulness of a second temporary vena cava filter for preventing acute pulmonary thromboemblism. Circ J 67:718–720PubMedCrossRef

54.

Rajasekhar A, Crowther M (2010) Inferior vena caval filter insertion prior to bariatric surgery: a systematic review of the literature. J Thromb Haemost 8:1266–1270PubMedCrossRef

55.

Hajduk B, Tomkowski WZ, Malek G, Davidson BL (2010) Vena cava filter occlusion and venous thromboembolism risk in persistently anticoagulated patients: a prospective, observational cohort study. Chest 137:877–882PubMedCrossRef

56.

Pons M, Riglietti A, Van den Berg JC (2010) The role of vena cava filters in the management of venous thromboembolism. J Cardiovasc Surg 51:355–364

57.

The PREPIC Study Group (2005) Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism. Circulation 112:416–422CrossRef

58.

Failla PJ, Reed KD, Summer WR, Karam GH (2005) Inferior vena caval filters: key considerations. Am J Med Sci 330:82–87PubMedCrossRef

59.

Brender E (2006) Use of emboli-blocking filters increases, but rigorous data are lacking. JAMA 295:989–990PubMedCrossRef

60.

Nicholson W, Nicholson WJ, Tolerico P et al (2010) Prevalence of fracture and fragment embolization of Bard retrievable vena cava filters and clinical implications including cardiac perforation and tamponade. Arch Intern Med 170:1827–1831PubMedCrossRef

Titel: Retrievable vena cava filters: a clinical review
verfasst von: Davide Imberti
Walter Ageno
Francesco Dentali
Marco Donadini
Roberto Manfredini
Massimo Gallerani
Publikationsdatum: 01.04.2012
Verlag: Springer US
Erschienen in: Journal of Thrombosis and Thrombolysis / Ausgabe 3/2012
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-011-0671-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2012

The association between soluble lectin-like oxidized low-density lipoprotein receptor-1 levels and patients with isolated coronary artery ectasia

Venous thromboembolism: a collaborative quality improvement model for practitioners, hospitals, and insurers

Persistent high on-treatment platelet reactivity in acute coronary syndrome

Impact of type of thrombolytic agent on in-hospital outcomes in ST-segment elevation myocardial infarction patients in the Middle East

Time-dependent changes in non-COX-1-dependent platelet function with daily aspirin therapy